pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
209
stories
4d
Opinion: STAT+: Dementia finally has a business model
stat
4d
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
stat
4d
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
biopharma dive
4d
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
biospace
4d
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
biopharma dive
4d
STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
stat
4d
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
biospace
4d
[Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus
biopharma dive
4d
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
5d
After missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaboration
fiercebiotech
5d
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
stat
5d
Denmark’s foundation‑fueled biotech boom redraws the Nordic map
biospace
5d
Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug
fiercebiotech
5d
Researchers find similar drug development to reimbursement timelines for major markets
raps
7d
Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
stat
7d
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
biospace
7d
Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
fiercebiotech
8d
Senate advances MAHA-friendly bill for food warning labels and junk food ad bans
stat
8d
Lilly, with new data, to seek FDA approval of obesity drug retatrutide
biopharma dive
8d
STAT+: FDA is urged by advocacy group to ban DTC prescription drug ads
stat
9d
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
biospace
9d
GSK lung cancer drug gets speedy approval following $10.6B deal
biopharma dive
9d
Former FDA cancer chief Pazdur says the agency should restructure
endpoints
9d
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
biospace
9d
Novartis scraps mid-stage radiopharma asset as Pluvicto soars
biospace
10d
Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drug
fiercebiotech
10d
As Maui recovers from devastating fires, a study offers vision for new rural health model
stat
10d
Novartis stays 'geography-agnostic' in dealmaking amid flurry of China deals
biospace
11d
Jupiter enters psychedelics space with $100M deal for PharmAla's MDMA drug
fiercebiotech
11d
Agios says adios to sickle cell program over lackluster phase 2 data
fiercebiotech
← prev
page 2 of 7
next →
